ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009

National Action Plan Issues RFA For Grant Supplements

April 21, 1995

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Lawrence Corey Named President Of Fred Hutchinson Cancer Research Center

August 6, 2010